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Background: The Body Mass Index (BMI) is a widely used parameter to study obesity; however it does not assess
the distribution of body adiposity. Ultrasonography is a reliable method of measuring subcutaneous (SAT), visceral
(VAT) and Total adipose tissue of the abdomen (TAT) to determine the influence of abdominal fat on pulmonary
function by directly measuring abdominal adipose tissue.
Methods: Eighty pre-menopausal, non-smoker, sedentary females with no history of pulmonary disease were
subdivided into three groups: 25 normal-weight, 28 overweight, 27 obese. Absolute and predictive spirometric
values were obtained: FVC, FEV1, FEV1/FVC, IC, ERV.
Results: A positive correlation between increased %IC and decreased %ERV was observed with increased BMI
(p < 0.02; 0.001 respectively); %FVC, %FEV1 and %ERV decreased significantly as SAT (p = 0.01, p = 0.02; p < 0.001)
and TAT (p = 0.01, p = 0.03, p < 0.001) increased, whereas VAT was negatively correlated only with %ERV (p < 0.001).
Increments of 5 mm in TAT, VAT and SAT were followed by a reduction of 0.83 %, 0.81 %, 1.90 % in %FVC,
respectively, as well as a reduction of 4.25 %, 4.31 % and 9.44 % in %ERV, respectively.
Conclusions: Subcutaneous abdominal adipose tissue deposition in obese females has a greater negative influence
on pulmonary function than visceral adipose tissue deposition.
Keywords: Abdominal adiposity deposition, Obesity, Respiratory function, Subcutaneous, Sonography, VisceralBackground and Availability of supporting data
section
Obesity has reached epidemic proportions in a number
of Western countries and is considered as one of the
main risk factors for the development of metabolic and
cardiac diseases, permanent disability and death [1].
Increase in body weight is less relevant than distribu-
tion of the adipose tissue in the development of meta-
bolic disorders [2]. Therefore, the frequently used Body
Mass Index (BMI), which does not take into account
such body fat distribution, is currently less accepted as a
reliable method of evaluating the correlation between
obesity and associated diseases [3]. Obesity, especially* Correspondence: ziedrasslan@uol.com.br
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ated with a number of co-morbidities. The main white
adipose tissues are abdominal subcutaneous adipose tis-
sue (SAT) and visceral adipose tissue (VAT) [4].
There are a number of imaging methods that assess
body fat distribution, such as dual-energy x-ray, com-
puted tomography, magnetic resonance, and sonography
[5]. Sonographic assessment is a good alternative to other
more sophisticated imaging techniques as it allows accur-
ate, reliable, reproducible and cost-effective noninvasive
collection of anthropometric data, with the added bonus
of being painless and not exposing patients to ionizing ra-
diation. This method also shows high correlation with
tomographic findings [6].
The specific influence of obesity in respiratory disor-
ders is complex and may depend on physical, mechan-
ical, inflammatory and metabolic factors [7]. Obesity hasrticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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monary function of obese females is influenced mainly by
the amount and centripetal distribution of the excessive
fat, which may interfere in the mechanics of the thoracic
dynamics [10].
Pulmonary function abnormalities are more commonly
seen in central obesity, however it is not completely
clear if these abnormalities are solely a response to
mechanical disturbances or if the changes in cellular me-
tabolism and the byproducts produced by this central fat
distribution also play a role in the respiratory problems
[11].
In a very interesting study involving 14 obese men,
Watson et al. hypothesized that thoracic expansion was
reduced by the load imposed by increased total trunk fat
volume or its distribution. However, the authors, using
MRI analysis to assess internal and subcutaneous fat
trunk and total abdominal and thoracic volumes at full
inflation, failed to support the hypotheses that restriction
of TLC, or impaired expansion of the thorax at full infla-
tion in middleaged obese men, was simply the conse-
quence of a large abdominal or total volume trunk fat
volume or its distribution [12].
There are a number of respiratory changes observed in
obese patients even in the absence of respiratory disease,
such as changes in the respiratory mechanism, decreased
muscle strength and gas changes, abnormal or border-
line pulmonary function tests, and limited ability to
perform exercises which are all directly related to incre-
ments in BMI [13–15].
The most common pulmonary function abnormalities
reported in obese females are: a reduction in the residual
expiratory volume (REV) proportional to the severity of
obesity; and a reduction in vital capacity (VC) and total
lung capacity (TLC) observed mostly in morbid obesity
[16].
The magnitude of pulmonary function impairment is
not always directly proportional to the severity of obes-
ity, and may also be influenced by gender and distribu-
tion of the adipose tissue [17, 18]. The majority of obese
females present spirometry values within normal pre-
dictive ranges. Even though several studies have ad-
dressed the influence of obesity on pulmonary function,
only a small number have focused on the effect of body
adipose tissue distribution [15, 19, 20].
The influence of body adipose tissue distribution on
pulmonary function of individuals who are overweight or
mildly obese also remains unclear; only a small number of
studies with this population included measurements of
central adiposity, finding a decreased pulmonary function
in non-obese individuals [18, 20–22].
The objective of the current study is to assess the ef-
fects of abdominal subcutaneous and visceral adipose
tissue deposition on the spirometric parameters of obesefemales comparing them to normal-weight and over-
weight females.
Methods
Following approval of the Ethics Committee on Human
Research of Santa Casa de São Paulo a total of 80 volun-
teer adult sedentary females who fitted the inclusion and
exclusion criteria were consecutively enrolled at a ter-
tiary teaching institution. All the participants consented
to participate in the study after properly informed.
In order to be considered sedentary, participants should
report physical activity equivalent to less than a 30-min
walk three times a week.
To be included in the study females should also be pre-
menopausal, over 22 and under 47 years of age, and have
no past history of cardiac and respiratory diseases, as well
as be non-smokers and have no recent respiratory com-
plaints. Females who reported the use of bronchodilators
or broncho constricting drugs, as well as those with sys-
temic diseases or who underwent surgery in the 6 months
prior to entering the study protocol were excluded.
All the participants were interviewed and responded
to a guided questionnaire that contained general epi-
demiological data and specific respiratory data. Weight
(in kilograms) and height (in meters) were obtained to
determine the BMI, which was used to establish obesity.
The participants were subdivided into three distinct
groups according to their body mass index: 25 females
with normal body weight (BMI ranging from 19 to 24.9
Kg/m2); 28 overweight females (BMI ranging from 25 to
29.9 Kg/m2); and 27 obese females (BMI greater than
30 Kg/m2).
Abdominal adiposity distribution
Abdominal adiposity distribution was then assessed using
sonography. Three measurements were obtained: subcuta-
neous adipose tissue (SAT), visceral adipose tissue (VAT),
and total adipose tissue of the abdomen (TAT = SAT +
VAT). All sonography examinations were performed by
the same experienced physician (co-author) using an
Image point Hewlett Packard, Chicago, USA and a 7.5
megahertz transducer. Volunteers were instructed to fast
for 12 h prior to the examination, which was then per-
formed in the supine position under natural breathing.
The transducer was placed longitudinally under pressure
in the midline of the abdomen at the level of the supra-
umbilical mesogastric area. The total thickness of the ab-
dominal adipose tissue, as well as that of the subcutaneous
and visceral adipose tissue was determined from frozen
images and expressed in centimeters (cm). Subcutaneous
adipose tissue thickness was calculated by measuring
the distance between the skin and the anterior portion of
the rectus abdominalis muscle. Visceral adipose tissue
thickness was established by measuring the distance
Table 1 Anthropometric, sonographic and spirometric data of
the studied population of 80 sedentary volunteer females
Variable Normal-Weight Overweight Obese
Mean ± SD Mean ± SD Mean ± SD p
n 25 28 27
Age (years) 31.2 ± 7.11 31.9 ± 6.85 32.9 ± 7.25 NS
Height (cm) 1.62 ± 0.09 1.63 ± 0.06 1.59 ± 0.08 NS
Weight (Kg) 59.1 ± 7.01 73.7 ± 6.12 84.5 ± 10.6 <0.001
BMI (kg/m2) 22.4 ± 1.57 27.8 ± 1.25 33.3 ± 2.18 <0.001
SAT (cm) 1.71 ± 0.38 2.52 ± 0.61 3.13 ± 0.65 <0.001
VAT (cm) 3.17 ± 0.53 4.04 ± 1.03 5.04 ± 1.47 <0.001
TAT (cm) 4.89 ± 0.68 6.56 ± 1.18 8.17 ± 1.54 <0.001
%FVC 102.5 ± 11.6 104.2 ± 12.2 100.6 ± 10 NS
%FEV1 99.4 ± 9.46 101.5 ± 12.1 99 ± 8.71 NS
FEV1/FVC 0.84 ± 0.04 0.83 ± 0.04 0.85 ± 0.05 NS
%IC 113 ± 16.2 125.9 ± 18 123 ± 12.8 0.02
%ERV 94.4 ± 30 79.6 ± 25.8 64 ± 25.7 0.001
%FVC, percent predictive Forced Vital Capacity, %FEV1, percent predictive
Forced Expiratory Volume in first second, SD, Standard Deviation, %IC, percent
predictive Inspiratory Capacity, %ERV, percent predictive Expiratory Reserve
Volume, BMI, Body Mass Index, NS, non-significant, n, number of individuals,
statistical significance (p < 0.05), BMI, Body Mass Index, TAT, Total abdominal
adipose tissue, VAT, Visceral adipose tissue, SAT, Subcutaneous adipose tissue
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muscle and the posterior wall of the aorta at the level of
the abdominal aorta bifurcation at the xyfo-umbilical line.
Total abdominal adipose tissue was determined by adding
the latter two measurements.
Pulmonary function
Pulmonary function was assessed with a Koko spirometer
associated to a pneumotacograph (nSpire Health Inc,
USA). All spirometric examinations were performed by
the same experienced pneumologist (co-author) in a quiet
and calm environment, with controlled temperature and
humidity, from 8:00 am to 12:00 pm, in order to avoid cir-
cadian influences.
Before commencing the spirometric test participants
rested 5 to 10 min and then were carefully instructed on
the techniques and objectives of the test. Spirometric
data were collected in the sitting position using a nasal
prong and standard protocol [23].
Both the absolute and the percent predictive values of
the following spirometric parameters were studied: Forced
Vital capacity (FVC), Forced Expiratory Volume in 1 ° sec-
ond (FEV1), the proportion between FEV1 and FVC
(FEV1/FVC ratio), Inspiratory Capacity (IC), and Expira-
tory Reserve Volume (ERV). In this study, we have consid-
ered the difference between Vital Capacity and Inspiratory
Capacity as the extrapolated value of ERV.
Both forced and non-forced spirometries were per-
formed for the determination of the time-volume and
flow-volume curves. The non-forced spirometry was per-
formed to obtain the pulmonary capacities and volumes.
The volume-time curve obtained from forced spirometry
was determined by selecting the best of three acceptable
runs and was used to extract the percent predictive Forced
Vital Capacity (%FVC), and the Forced Expiratory Volume
in 1 ° second (%FEV1) [24]. The flow-volume curve was
also submitted to criteria of acceptability and adopted pre-
dictive values recommended by the ATS [23].
The percent predictive IC and ERV were correlated to
pairs of groups (normal-weight vs overweight; normal-
weight vs obese; overweight vs obese).
Results were tabled and analyzed statistically using a com-
mercially available software package (Statistical Package for
Social Science version 17.0). Parametric data were analyzed
using Spearman’s correlation test in order to try to establish
any possible correlation between BMI, total abdominal
adipose tissue, subcutaneous adipose tissue, visceral adi-
pose tissue, and spirometric parameters. Kruskal-Wallis
test was used to establish differences among the three BMI
groups for the studied parameters. When a statistically sig-
nificant difference was found, the variables were treated
with Mann–Whitney to compare paired groups. Multivar-
iance regression tests were used to study the influence of
qualitative and quantitative variables on the reduction of theERV. Variables were expressed in mean values and standard
deviations with a significance level established at p < 0.05.Results
All the studied obesity parameters (weight, BMI,
TAT, SAT, VAT) were significantly different among the
three BMI groups (normal-weight, overweight and
obese) (p < 0.001) (Table 1).
The percent predictive ERV was significantly reduced
in the three groups (p = 0.001), whereas the percent pre-
dictive IC was significantly increased in these groups
(p = 0.02). The percent predictive FVC and FEV1 presented
a significant negative correlation with SAT (r – 0.26;
p = 0.019 and r – 0.24; p = 0.026), respectively (Table 2).
No significant correlation was found between FEV1/FVC
and %IC and SAT (r = 0.15; p = 0.18 and r = 0.21; p = 0.058,
respectively) or VAT (r = 0.01; p = 0.86 and r = 0.09;
p = 0.42, respectively) (Table 2). The percent predictive
ERV presented a significant negative correlation with sub-
cutaneous, visceral and total abdominal adipose tissue
(r – 0.56; p < 0.001 and r – 0.36; p = 0.001 and r–0.54;
p < 0.001 respectively) (Figs. 1, 2 and 3). The percent pre-
dictive FVC and FEV1 also showed a significant negative
correlation with total abdominal adipose tissue (r- 0.27;
p = 0.015 and r- 0.24; p = 0.031, respectively) and subcuta-
neous adipose tissue (r- 0.26; p = 0.019 and r- 0.24;
p = 0.026, respectively) (Table 2). In our study, we have real-
ized that age and height are possible bias, so correlated with
Table 2 Correlation between spirometric parameters and abdominal adipose tissue (total, subcutaneous and visceral) measurements
of the 80 studied pre-menopausal females
Variable Subcutaneous Adipose Tissue Visceral Adipose Tissue Total Abdominal Adipose Tissue
r p r p r p
%FVC −0.26 0.01 −0.20 0.06 −0.27 0.01
%FEV1 −0.24 0.02 −0.17 NS −0.24 0.03
FEV1/FVC 0.15 NS 0.01 NS 0.09 NS
%IC 0.21 0.058 0.09 NS 0.18 NS
%ERV −0.56 <0.001 −0.36 0.001 −0.54 <0.001
%FVC, percent predictive Forced Vital Capacity, %FEV1, percent predictive Forced Expiratory Volume in first second, %IC, percent predictive Inspiratory Capacity,
%ERV, percent predictive Expiratory Reserve Volume, NS, non-significant, r, Pearson’s correlation coefficient
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lute values and the results were not positive, as expected.
When observing the paired groups (normal-weight vs
overweight; normal-weight vs obese; overweight vs obese),
the variable percent predictive IC presented a significant
positive correlation with the pairs normal-weight vs over-
weight and normal-weight vs obese. For the variable percent
predictive ERV values a significant negative correlation was
observed in all three pairs (Table 3).
Increments in 5 mm in total abdominal adipose tissue, vis-
ceral adipose tissue, and subcutaneous adipose tissue
reflected on a drop of 0.83 %, 0.81 %, and 1.90 % in the per-
cent predictive FVC, respectively (Table 4). The same was
observed for percent predictive ERV values, which dropped
4.25 %, 4.31 %, and 9.44 %, respectively following 5mm in-
crements in total abdominal adipose tissue, visceral adipose
tissue and subcutaneous adipose tissue (Table 4).Fig. 1 Correlation between subcutaneous adipose tissue and the
percentage of predictive values of the Expiratory Reserve Volume (%ERV)A multivariate analysis was used to compare BMI with
significant reductions in the percentages of the predict-
ive values of ERV in overweight and obese females.
Increments in subcutaneous and total adiposity were
followed by a significant reduction in the percentages of
predictive values of ERV in overweight (p = 0.001 e
0.009) and obese females (p < 0.001). Increments in vis-
ceral adiposity thickness were followed by a significant
reduction in the ERV of obese females (p = 0.007).
The multivariate analysis showed that in obese females
subcutaneous, visceral and total abdominal fat deposi-
tions increase the risk of reduction in the percentages of
predictive values of ERV in over 14, 9, and 25 times, re-
spectively (Table 5). In overweight females, subcutane-
ous and total abdominal fat depositions increase the risk
of a reduction in the percentages of predictive values of
ERV in over 10 and 4 times, respectively (Table 5).Fig. 2 Correlation between visceral adipose tissue and the percentage
of predictive values of the Expiratory Reserve Volume (%ERV)
Fig. 3 Correlation between total abdominal adipose tissue and the
percentage of predictive values of the Expiratory Reserve Volume
(%ERV)
Table 4 Effects of 5mm increments in abdominal adipose
tissue on the percentage of predictive values of the Forced Vital






TAT 0.83 % 4.25 %
VAT 0.81 % 4.31 %
SAT 1.90 % 9.44 %
%FVC, percentage of predictive Forced Vital Capacity, %ERV, percentage of
predictive Expiratory Reserve Volume, TAT (cm), Total abdominal adipose
tissue, VAT (cm), Visceral adipose tissue, SAT (cm), Subcutaneousadipose tissue
Table 5 Results of multiple regression analysis for the percent
predictive ERV including body mass index and sonographic
measurement (subcutaneous, visceral and total abdominal
adipose tissue)
Variable OR IC 95 % p
BMI
Normal weight≤ 24.9
Overweight 3.96 1.25-12.6 0.010
Obese 9.00 2.55-31.2 0.001
SAT
Normal weight≤ 2.09
Overweight 10.7 3.36-34.4 <0.001
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The current study was motivated by the knowledge that
adipose tissue distribution is essential for determining
the effects of obesity on the mechanics of the respiratory
system. BMI alone is not reliable to determine specific
risk factors for the development of associated diseases in
obese patients, as it does not account for the distribution
of body adiposity [21]. In the current study the compari-
son of abdominal adipose deposition (total abdominal
adipose tissue, visceral adipose tissue and subcutaneous
adipose tissue) with the pulmonary function of normal-
weight, overweight, and obese premenopausal females
revealed significant differences in all the spirometric
values studied.
Although a number of studies have also observed an
inverse correlation between respiratory function and
obesity, as well as specific body adiposity distribution
[10, 22, 25], the current study is, to authors’ knowledge,
the first one to correlate abdominal wall thickness
measured by sonography with its subdivisions (visceralTable 3 Comparison between pairs of BMI groups according to
percentages of predictive values of the Inspiratory Capacity and
Expiratory Reserve Volume




%IC 0.01a 0.02a NS
%ERV 0.04a 0.001a 0.04a
aStatistical significance on Mann–Whitney test; NS, non-significant, %IC,
percentage of predictive Inspiratory Capacity, %ERV, percentage of predictive
Expiratory Reserve Volumeand subcutaneous) to spirometric values. In accordance
with the literature [10], no significative spirometric dif-
ferences were observed among normal-weight, over-
weight and obese females. However, when abdominal
adiposity distribution was correlated to spirometric
values in this otherwise healthy sample of females, a sig-
nificant negative correlation was found, suggesting that
abdominal adipose tissue deposition (subcutaneous and
total) interferes in the capacity of sustaining the max-
imum expired volume after maximum inspiration. These
findings suggest that total abdominal adipose tissue and
subcutaneous adipose tissue may predict a reduction in
spirometric values in this population.Obese 14.9 3.27-66.6 <0.001
VAT
Normal weight≤ 3.7
Overweight 1.33 0.48-3.67 0.570
Obese 9.25 1.85-45.4 0.007
TAT
Normal weight≤ 5.57
Overweight 4.38 1.45-13.3 0.009
Obese 25.6 4.71-142.8 <0.001
OR, odds ratio, IC, confidence interval, p, significance, BMI, Body mass índex,
TAT, Total abdominal adipose tissue, VAT, Visceral adipose tissue, SAT,
Subcutaneous adipose tissue
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most likely determines a limitation in the mobility of the
abdominal and thoraco-abdominal muscles. Visceral adi-
pose tissue deposition, on the other hand, is expected
to limit diaphragmatic mobility. Association of both
SAT and VAT deposition may also lead to restricted lung
expansion during inspiration and reduction in the cali-
ber of the peripheral airways causing abnormalities in
perfusion/ventilation and developing hypoxemia [26].
These abnormalities may explain the higher prevalence
of respiratory problems in obese females, particularly
when under exertion or in the supine position (sleeping
or under anaesthesia) [26].
It is also important to determine if there is a specific
pattern of fat deposition that is most likely to cause the
changes described above. The females who participated
in the current study were all pre-menopausal. In this
stage adipose tissue distribution tends to be more per-
ipheral (femoral and gluteous) than abdominal. Interest-
ingly, the studied population showed that total fat, both
visceral and subcutaneous depot influenced ERV in a
statistically significant manner (Table 2). By studying in-
crements of 5mm in adipose tissue distribution, it was
observed that subcutaneous adipose tissue increments
were the ones with the most significant negative correl-
ation with pulmonary function parameters such as FVC
and ERV (Table 4).
A number of factors are involved in the pulmonary ab-
normalities found in obese females, other than the
mechanical ones described above. Abdominal adiposity
has been correlated to insulin resistance, abnormalities
in the metabolism of glucose, hypertension and dyslipid-
emia, all known conditions associated with the metabolic
syndrome [27]. Females present significantly higher lep-
tine levels than males with the same BMI, suggesting
that this peptide may play a role in gender differences
found between adipose tissue deposition and respiratory
function [28]. Dysregulation of adipokine secretion, free
fatty acid toxicity, and the site-specific differences in ab-
dominal (visceral) versus subcutaneous adipose tissue
support abdominal obesity as a causal factor mediating
the insulin resistance, increased risk of diabetes, and car-
diovascular disease in the metabolic syndrome [29].
The study by Torchio et al. suggests that obesity and
airway responsiveness are associated. This is true in both
sexes. In men, the relationship appears to be linked to
the effects of obesity on lung volumes and breathing
control. In women, the relationship is presumably more
complex and possibly involves additional biological/bio-
chemical mechanisms other than breathing control [30].
When subdividing the studied population into groups
according to weight and comparing them two by two
(normal-weight vs overweight; normal-weight vs obese;
overweight vs obese) the reduction in the %ERV and theincrease in the %IC, following increments in BMI, sus-
tained the findings of the overall group.
No significant differences were found in the %FVC
and %FEV1 among the original three BMI groups (nor-
mal-weight, overweight, and obese). According to Harik-
khan et al. [17], it is the subcutaneous fat deposition in
the upper thorax rather than abdomen that determines
the greatest impact on respiratory function. However, in
the current study subcutaneous adiposity and total ab-
dominal adiposity were found to have a significant nega-
tive impact on respiratory function of the obese females.
It is very important speculate that the main abnormal-
ities in obesity are the transmission of the high pressures
in the intra-abdominal compartment to the thorax that
dramatically reduce functional residual capacity and ex-
piratory reserve volume and oblige patients to breathe
on the flatter, less efficient, part of their pressure-volume
curve, increasing the work of breathing.
Steier et al. [31] conducted an observational study of
lung volume and elasticity in nine obese and nine regular
weight subjects, seated and supine, during spontaneous
breathing. Seated and supine total lung capacity (TLC) and
subdivisions were measured by multibreath helium dilution
method. Using balloon catheters, oesophageal and gastric
pressures were recorded. Transpulmonary pressure was
calculated by the mouth pressure minus oesophageal pres-
sure, and complete expiratory volume curves transpulmon-
ary pressure were measured. The obese subjects were
more restricted than the normals, had dramatically re-
duced expiratory reserve volume and end-tidal functional
residual capacity (FRC) was smaller when seated, but was
similar when supine. Gastric pressures at FRC were signifi-
cantly elevated in the obese, as were the end-expiratory
oesophageal pressures at FRC. BMI correlated with end-
expiratory gastric and oesophageal pressures. Therefore,
according to authors obese subjects have markedly in-
creased gastric and oesophageal pressures, both when up-
right and supine, causing dramatically reduced FRC and
ERV, which increases work of breathing.
In 2009 Leone et al. also observed a positive correlation
between pulmonary dysfunction and metabolic syndrome
in females, independent from other cardiovascular risk
factors or even BMI, especially in those with abdominal
adiposity [20]. Metabolic syndrome and abdominal adi-
posity are associated with a restrictive respiratory pattern,
where the greater the abdominal circumference the worse
is the FVC [20, 30]. Although literature considers visceral
adipose tissue deposition to cause a greater metabolic,
mechanical and hormonal effect on pulmonary function
than subcutaneous adipose tissue deposition [30, 32], this
did not seem to be the case in the population of over-
weight and obese females studied in the current series.
Visceral adipose tissue deposition most likely plays an
important role in males, but seems to have less impact on
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ity for determining abdominal adoposity [29]. It also
seems the speed of weight gain may play a role in the de-
velopment of respiratory impairment, as females that gain
weight slowly over time do not present significant spiro-
metric changes, suggesting that the body develops adap-
tive mechanisms to the excessive adipose tissue.
In 2008 Sutherland et al. studied the effect of adiposity
measured by dual-energy x-ray absorptiometry on lung
function in healthy adults finding that BMI was only
weakly associated with pulmonary volumes [32]. How-
ever, all the indicators of localized body fat deposition
presented a significant negative correlation with FVC
and ERV in both males and females, but especially in fe-
males. Some studies suggest that obesity is a risk factor
for small airways disease and may be associated to exer-
cise intolerance found in overweight and obese healthy
adults [33].
According to Farah et al. [34], the obese asthma
phenotype is increasingly encountered in clinical prac-
tice. Epidemiological data indicate that obesity increases
the prevalence and incidence of asthma, and evidence
that obesity precedes the development of asthma raising
the possibility of a causal association. Despite more than
a decade of research into this association, the exact
mechanisms that underlie the interaction of obesity with
asthma remain unclear. It is unlikely that the asthma-
obesity association is simply due to comorbidities such
as obstructive sleep apnea or gastroesophageal reflux
disease.
The clinical implication of weight gain is an overload
in the respiratory muscles caused by a superior displace-
ment of the diaphragm, which determines a decrease in
the ERV and FRC, and may lead to dyspnea upon exer-
tion in obese women [18].
Aguiar et al. [35] in a study involving 16 obese men and
women undergoing bariatric surgery, observed a significant
improvements of FVC (p = 0.002) and FEV1 (p = 0.003)
after bariatric surgery. Analyzing the ventilatory maximum
pressures only in obese women in the preoperative period,
the authors observed a significant reduction of maximum
inspiratory pressures (52.67 ± 18.91) and maximum ex-
piratory pressures (53.58 ± 16.88) in comparison to the
reference values and a significant increase in pressures
occurred in the postoperative period (MIP = 0.002 and
MEP = 0.001). Therefore, the authors concluded that
the reduction of adipose tissue caused by bariatric sur-
gery effectively increases maximum ventilatory pres-
sures and pulmonary function in patients with severe
obesity.
The current findings of decreased pulmonary function
associated to increased subcutaneous and visceral adi-
pose tissue deposition in overweight and obese females
corroborate the above studies.Conclusions
The authors conclude that the progressive gain in BMI
and the pattern of abdominal adipose tissue distribution,
especially subcutaneous adipose tissue, interfere with the
ERV of overweight and obese females. Further studies
with larger populations and a longitudinal design are
needed to better clarify these findings.
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